Search

Background: With the increasing global prevalence of type 2 diabetes (T2D) and obesity, there is a pressing need for novel therapeutic interventions. Lavandula stoechas, a medicinal plant traditionally used for various ailments, holds promise as a potential agent for T2D management, particularly in Morocco, where it is commonly used to treat diabetes. This study aims to evaluate the pharmacological potential of L. stoechas aqueous extract (AqLs) by assessing its lipase inhibition antioxidant and anti-inflammatory activities, identifying phenolic compounds, and examining its efficacy in reducing diabetic complications. Methods: The pharmacological potential of L. stoechas aqueous extract was investigated using in vitro assays. The inhibitory effect on pancreatic lipase, antioxidant power (FRAP), and anti-inflammatory activity (albumin denaturation method) was assessed. High-performance liquid chromatography (HPLC) analysis identified phenolic compounds. Additionally, albumin glycation was evaluated by estimating fructosamine, carbonyl groups, and amyloid β-structures to assess efficacy in mitigating diabetic complications. Results: The extract demonstrated concentration-dependent inhibition of pancreatic lipase (IC50 = 0.132 ± 0.006 mg/mL), potent antioxidant activity (IC50 = 604.99 ± 1.01 μg/mL), and dose-dependent anti-inflammatory effects (IC50 = 207.01 ± 34.94 mg/mL). HPLC analysis revealed phenolic compounds: naringin (38.28%), syringic acid (25.72%), and cinnamic acid (15.88%) were the most abundant, with 4-hydroxybenzoic acid, hydrated catechin, and catechin ranging from 9.60% to 5.24%, and p-coumaric acid (1.73%). Furthermore, the extract inhibited albumin glycation and fructosamine production, suggesting efficacy in mitigating diabetic complications. Conclusion: These findings highlight the multifaceted pharmacological potential of L. stoechas aqueous extract in T2D management, suggesting that this plant can be highly beneficial for diabetic individuals. [ABSTRACT FROM AUTHOR]

Climate change poses a threat to plant and animal biodiversity. It induces physiological and morphological changes in plants. This study aimed to assess the effect of climate change on the phytochemical constituents, essential oil yield and chemical composition of Inula viscosa leaves. Three samples of I. viscosa from the Taounate region of Morocco were cultivated in a closed chamber for three years under different climatic conditions: sample 1 (I. viscosa cultivated in the first year under normal temperature and precipitation conditions of Taounate region), sample 2 (I. viscosa cultivated in the second year, at 5°C increase in temperature and 50% decrease in precipitation), and sample 3 (I. viscosa cultivated in the third year, at 10°C increase in temperature and 75% decrease in precipitation). Phytochemical and mineral analyses of the three samples were done according to standard procedures. Essential oils were extracted from the leaves of the three samples by hydro-distillation using the Clavenger apparatus. Chemical composition of the essential oils was identified by gas chromatography-mass spectrometric (GC-MS) analysis. Phytochemical screening showed that moderately intensified climatic conditions (sample 2) led to an increase in phytochemical content, mineral composition, and essential oil yield of Inula viscosa leaves. However, at adverse climatic conditions (sample 3), the phytochemical content, mineral composition, and essential oil yield of Inula viscosa leaves decreased significantly. GC-MS analysis revealed that changes in climatic condition affected the content of major compounds in the essential oil of I. viscosa leaves. Therefore, climate change can significantly impact the chemical composition of plants. [ABSTRACT FROM AUTHOR]

In this study, the authors aimed to compare the phytochemical compounds (polyphenols and flavonoids), antioxidant activity, functional groups present in the compounds (FTIR), and anti-microbial effects, in the aqueous and methanol extracts obtained from flowers of commercial Hypericum perforatum and native Papaver Rhoeas from Morocco. P. Rhoeas L was collected from El Lhaj Kaddour near Meknes, while H. perforatum L was bought in a dried state from a Moroccan herbalist in the same city. Total polyphenols were evaluated using the Folin-Ciocalteu reagent, respectively. The antioxidant activity was assessed via DPPH and antimicrobial effects were tested against six bacteria (Gram- and Gram+). The aqueous and methanol extracts of P. Rhoeas had the highest TPC value (23.67 ± 0.94 mg GAE/g; 15.86 ± 0.65 mg GAE/g) compared to H. perforatum (15.26 ± 1.30 mg GAE/g; 5.50 ± 1.13 GAE/g). The aqueous extract of Papaver Rhoeas exhibited the highest TFC at 14.36 ± 0.49 mg QE/g, while the methanol extract of Hypericum perforatum had the highest 10.65 ± 0.49 mg QE/g in TFC. In contrast, the methanol and aqueous extracts of H. perforatum showed significant zones of inhibition against Staphylococcus aureus (9.5 ± 0.5 mm and 10.17 ± 0.29 mm) and Staphylococcus epidermidis (8.33 ± 0.58 mm and 9.33 ± 0.58 mm) respectively, with a minimum inhibitory concentration was estimated at 10 µL/ml. The FTIR analysis demonstrated that the extracts of both plants are rich in bioactive molecules with potential biological activities and a pharmaceutical industry perspective. Consequently, these Papaver Rhoeas and Hypericum perforatum extracts exhibit antioxidant and antibacterial activities. [ABSTRACT FROM AUTHOR]

Cannabis is considered (Cannabis sativa L.) a sacred herb in many countries and is vastly employed in traditional medicine to remedy numerous diseases, such as diabetes. This research investigates the chemical composition of the aqueous extracts from Cannabis sativa L. seeds. Furthermore, the impact of these extracts on pancreatic α-amylase and lipase, and intestinal α-glucosidase enzymes is evaluated, as well as their antihyperglycemic effect. Analysis of the chemical composition of the aqueous extract was conducted using high-performance liquid chromatography with a photodiode array detector (HPLC-DAD). In contrast, the ethanol, hexanic, dichloromethane, and aqueous extract compositions have been established. Additionally, the inhibitory effects of ethanolic, dichloromethane, and aqueous extracts on pancreatic α-amylase and lipase, and intestinal α-glucosidase activities were evaluated in vitro and in vivo. The results of HPLC analysis indicate that the most abundant phenolic compound in the aqueous cannabis seed extract is 3-hydroxycinnamic acid, followed by 4-hydroxybenzoic acid and rutin acid. Moreover, administration of ethanolic and aqueous extracts at a dose of 150 mg/Kg significantly suppressed postprandial hyperglycemia compared to the control group; the ethanolic, dichloromethane, and aqueous extracts significantly inhibit pancreatic α-amylase and lipase, and intestinal α-glucosidase in vitro. The pancreatic α-amylase test exhibited an inhibition with IC50 values of 16.36 ± 1.24 µg/mL, 19.33 ± 1.40 µg/mL, 23.53 ± 1.70 µg/mL, and 17.06 ± 9.91 µg/mL for EAq, EDm, EET, and EHx, respectively. EET has the highest inhibitory capacity for intestinal α-glucosidase activity, with an IC50 of 32.23 ± 3.26 µg/mL. The extracts inhibit porcine pancreatic lipase activity, demonstrating their potential as lipase inhibitors. Specifically, at a concentration of 1 mg/mL, the highest inhibition rate (77%) was observed for EDm. To confirm these results, the inhibitory effect of these extracts on enzymes was tested in vivo. The oral intake of aqueous extract markedly reduced starch- and sucrose-induced hyperglycemia in healthy rats. Administration of the ethanolic extract at a specific dose of 150 mg/kg significantly reduced postprandial glycemia compared with the control group. It is, therefore, undeniable that cannabis extracts represent a promising option as a potentially effective treatment for type 2 diabetes. [ABSTRACT FROM AUTHOR]

Thymus vulgaris L. (family Lamiaceae) is an aromatic medicinal plant well-known for its essential oil and therapeutic values. It thrives across Europe, Western Asia, the Mediterranean, and Northwestern Africa. This study aims to investigate the effect of climate change on the chemical composition, antioxidant, and antidiabetic activities of Thymus vulgaris essential oil. Essential oils were extracted from three distinct Thymus vulgaris samples (S1 - S3) cultivated under different climatic conditions. S1 was cultivated under normal seasonal condition; S2 and S3 were cultivated under controlled conditions; 5°C temperature increase and 50% precipitation (S2), 10°C temperature increase and 75% precipitation (S3). Chemical constituents of the essential oils were identified using Gas Chromatography-Mass Spectrometry (GC-MS). The antioxidant activity was assessed using the 2,2-Diphenyl-1-picrylhydrazyl (DPPH), 2,2'-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) radical scavenging, and Ferric Reducing Antioxidant Power (FRAP) assays. The antidiabetic activity was assessed via the a-glucosidase and a-amylase inhibitory activities. GC-MS analysis identified 23 compounds with varying proportions in the three essential oil samples. The findings showed that S1 had the most potent antioxidant activity with IC50 values of 461.83±10.49 µg/mL and 1508.83±7.22 µg/mL in the DPPH and ABTS assays, respectively, while S3 exhibited the highest antioxidant activity in the FRAP assay, with IC50 value of 244.64±1.34 µg/mL. For the antidiabetic activity, S1 showed the highest a-amylase inhibitory activity, while S2 exhibited the highest a-glucosidase inhibitory effect. This study sheds light on Thymus vulgaris' adaptability and therapeutic potential under changing climatic conditions. These findings underscore the importance of understanding these dynamics for future applications. [ABSTRACT FROM AUTHOR]

In the present investigation, the phenolic compounds of Solanum elaeagnifolium were identified, and the plant's anti-lipase and anti-glycation effects on hemoglobin were discovered through in vitro experiments, as well as its short-term antihyperglycemic and anti-inflammatory effects. The chemical compound composition was detected using HPLC-DAD, the anti-lipase activity was tested in vitro using 4-nitrophenyl butyrate as a substrate, and the antiglycation activity of the plant extracts was also tested in vitro using a haemoglobin model. The antihyperglycemic effect was determined by inhibiting pancreatic α-amylase and α-glycosidase activity and performing an in vivo glucose tolerance test on normal rats, and the anti-inflammatory activity was determined by inducing paw inflammation with carrageenan. In both the SEFR (fruit) and SEFE (leaf) extracts, chromatographic analysis revealed the presence of quercetin 3-O-β-D-glucoside, rutin, and quercetin. SEFR inhibited the pancreatic lipase enzyme more effectively, with an IC50 of 0.106 ± 0.00 mg/mL. S. elaeagnifolium extracts demonstrated significant antiglycation activity, with 3.990 ± 0.23 mg/mL of SEFE and 3.997 ± 0.14 mg/mL of SEFR. When compared to positive and negative controls, plant extracts had very significant anti-diabetic and anti-inflammatory effects. The findings in this study and previous research on this plant encourage us to investigate other pharmacological activities of this plant besides its duiretic, cictrisant, and anti-ulcer activity. [ABSTRACT FROM AUTHOR]

Opuntia ficus indica L (Cactaceae), is commonly employed in Morocco as an alternative medicinal approach for managing diabetes mellitus (DM). The objective of the study is to explore and examine novel mechanism underlying the antidiabetic activity of Opuntia ficus indica seed oil (OFIO), which has shown promising potential in managing diabetes, but the exact mechanisms responsible for its antidiabetic effects remain unclear. Therefore, the current study explores the antihyperglycemic effectof OFIO, the in vitro antioxidant properties, and the antiglycation activity of OFIOof hemoglobin (Hb) model. The total phenolic levels were determined using Folin-Ciocalteu colorimetric approach and total flavonoid levels were determined using colorimetric assay with aluminum chloride. The effect of antihyperglycemia was evaluated using the inhibitory effect of pancreatic a-amylase activity both in vitro and in vivo using Alloxan induced-diabetic rats and the glucose uptake in an isolated rat hemidiaphragm in vitro model. The antioxidant activity was studied using the DPPH Radical scavenging activity test. In addition, the antiglycation activity of OFIO was also tested in-vitro using hemoglobin model. The outcomes derived from this research have demonstrated that OFIO exhibited potent a-amylase inhibitory activity in vitro (p < 0.01; IC50 values of 4.24 ±0.18 mg/ml, and 4.05± 0.08 mg/ml respectively) and in vivo using Alloxan induced-diabetic rats. In contrast, OFIO has no effect on glucose uptake by the rat diaphragm muscle as compared to negative control. In addition, OFIO showed a significant antioxidant and hemoglobin antiglycation activities (p<0.001) with an IC50 value of 2.05± 0.06 mg/ml, and 0.485± 0.017 mg/ml, respectively. The findings of this study suggest that is OFIO has promising antidiabetic activity. [ABSTRACT FROM AUTHOR]